J&J booster cuts back on Omicron hospital admissions: study

A booster dose of Johnson & Johnson Inc.’s single-dose COVID-19 vaccine was 84% ​​effective in preventing hospitalization in South African healthcare workers who became infected as the Omicron variant spread, researchers said Thursday. Olivia Chan reports.

.

Leave a Comment